Cover Image
市場調查報告書

體外診斷 (IVD) 的美國市場的展望:臨床化學、遺傳基因檢驗、血液學的檢驗、組織學的檢驗及細胞診斷檢驗、免疫化學、感染疾病診斷、微生物培養

United States In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

出版商 GlobalData 商品編碼 346087
出版日期 內容資訊 英文 680 Pages
訂單完成後即時交付
價格
Back to Top
體外診斷 (IVD) 的美國市場的展望:臨床化學、遺傳基因檢驗、血液學的檢驗、組織學的檢驗及細胞診斷檢驗、免疫化學、感染疾病診斷、微生物培養 United States In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
出版日期: 2015年08月14日 內容資訊: 英文 680 Pages
簡介

本報告提供美國的體外診斷 (IVD) 所採用的試劑、設備、系統的市場相關調查,各類別及主要產品種類的收益規模的變化與預測,銷售處的佔有率實際成果,企業的佔有率實際成果,主要企業概要,開發平台,企業間的財務交易趨勢等彙整資料。

第1章 目錄

第2章 簡介

第3章 美國的體外診斷市場

  • 收益的變化與預測
  • 收益結構:實際成果
  • 收益實際成果:各類別明細
  • 收益的變化與預測:各分類的比較
  • 收益:到目前為止的轉變
  • 收益:今後的預測
  • 收益的企業市場佔有率實際成果

第4章 美國的臨床化學市場

  • 收益結構:實際成果
  • 收益實際成果:各類別明細
  • 收益:到目前為止的轉變
  • 收益:今後的預測
  • 收益的銷售處佔有率實際成果
  • 收益的企業市場佔有率實際成果

第5章 美國的遺傳基因檢驗市場

  • 收益結構:實際成果
  • 收益實際成果:各類別明細
  • 收益:到目前為止的轉變
  • 收益:今後的預測
  • 收益的銷售處佔有率實際成果
  • 收益的企業市場佔有率實際成果

第6章 美國的血液學的檢驗市場

  • 收益結構:實際成果
  • 收益實際成果:各類別明細
  • 收益:到目前為止的轉變
  • 收益:今後的預測
  • 收益的銷售處佔有率實際成果
  • 收益的企業市場佔有率實際成果

第7章 美國的組織學的檢驗及細胞診斷檢驗市場

  • 收益結構:實際成果
  • 收益實際成果:各類別明細
  • 收益:到目前為止的轉變
  • 收益:今後的預測
  • 收益的銷售處佔有率實際成果
  • 收益的企業市場佔有率實際成果

第8章 美國的免疫化學市場

  • 收益結構:實際成果
  • 收益實際成果:各類別明細
  • 收益:到目前為止的轉變
  • 收益:今後的預測
  • 收益的銷售處佔有率實際成果
  • 收益的企業市場佔有率實際成果

第9章 美國的感染疾病診斷市場

  • 收益結構:實際成果
  • 收益實際成果:各類別明細
  • 收益:到目前為止的轉變
  • 收益:今後的預測
  • 收益的銷售處佔有率實際成果
  • 收益的企業市場佔有率實際成果

第10章 美國的微生物培養市場

  • 收益結構:實際成果
  • 收益實際成果:各類別明細
  • 收益:到目前為止的轉變
  • 收益:今後的預測
  • 收益的銷售處佔有率實際成果
  • 收益的企業市場佔有率實際成果

第11章 主要企業概要

  • Siemens Healthcare
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • bioMerieux S.A.
  • Qiagen N.V.
  • Bio-Rad Laboratories, Inc.
  • Alere Inc.
  • Thermo Fisher Scientific Inc.
  • Immucor, Inc.
  • Ortho-Clinical Diagnostics Inc.
  • Sysmex Corporation
  • Cepheid
  • PerkinElmer, Inc.

第12章 體外診斷市場:開發中產品

第13章 財務交易

  • 收購
  • 資產交易
  • 債券發行
  • 股票上市
  • 合併
  • 聯盟
  • 私人股權
  • 創業資金

第14章 附錄

圖表

目錄
Product Code: GDMEMC0091DB

GlobalData's new report, "United States In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture", provides key market data on the United States In Vitro Diagnostics market. The report provides value, in millions of US dollars within market segments - Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for In Vitro Diagnostics market.
  • Global corporate-level profiles of key companies operating within the United States In Vitro Diagnostics market.
  • Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. In Vitro Diagnostics Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. In Vitro Diagnostics Market, United States

  • 3.1. In Vitro Diagnostics Market, United States, Revenue ($m), 2007-2021
  • 3.2. In Vitro Diagnostics Market, United States, Revenue Mix ($m), 2014
  • 3.3. In Vitro Diagnostics Market, United States, Category Contribution by Revenue ($m), 2014
  • 3.4. In Vitro Diagnostics Market, United States, Category Comparison by Revenue ($m), 2007-2021
  • 3.5. In Vitro Diagnostics Market, United States, Revenue ($m), 2007-2014
  • 3.6. In Vitro Diagnostics Market, United States, Revenue ($m), 2014-2021
  • 3.7. In Vitro Diagnostics Market, United States, Company Share by Revenue ($m), 2014

4. Clinical Chemistry Market, United States

  • 4.1. Clinical Chemistry Market, United States, Revenue Mix ($m), 2014
  • 4.2. Clinical Chemistry Market, United States, Segment Contribution (%), 2014
  • 4.3. Clinical Chemistry Market, United States, Revenue ($m), 2007-2014
  • 4.4. Clinical Chemistry Market, United States, Revenue ($m), 2014-2021
  • 4.5. Clinical Chemistry Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 4.6. Clinical Chemistry Market, United States, Company Share by Revenue ($m), 2014

5. Genetic Testing Market, United States

  • 5.1. Genetic Testing Market, United States, Revenue Mix ($m), 2014
  • 5.2. Genetic Testing Market, United States, Segment Contribution (%), 2014
  • 5.3. Genetic Testing Market, United States, Revenue ($m), 2007-2014
  • 5.4. Genetic Testing Market, United States, Revenue ($m), 2014-2021
  • 5.5. Genetic Testing Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 5.6. Genetic Testing Market, United States, Company Share by Revenue ($m), 2014

6. Haematology Market, United States

  • 6.1. Haematology Market, United States, Revenue Mix ($m), 2014
  • 6.2. Haematology Market, United States, Segment Contribution (%), 2014
  • 6.3. Haematology Market, United States, Revenue ($m), 2007-2014
  • 6.4. Haematology Market, United States, Revenue ($m), 2014-2021
  • 6.5. Haematology Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 6.6. Haematology Market, United States, Company Share by Revenue ($m), 2014

7. Histology And Cytology Market, United States

  • 7.1. Histology And Cytology Market, United States, Revenue Mix ($m), 2014
  • 7.2. Histology And Cytology Market, United States, Segment Contribution (%), 2014
  • 7.3. Histology and Cytology Market, United States, Revenue ($m), 2007-2014
  • 7.4. Histology and Cytology Market, United States, Revenue ($m), 2014-2021
  • 7.5. Histology and Cytology Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 7.6. Histology and Cytology Market, United States, Company Share by Revenue ($m), 2014

8. Immuno Chemistry Market, United States

  • 8.1. Immuno Chemistry Market, United States, Revenue Mix ($m), 2014
  • 8.2. Immuno Chemistry Market, United States, Segment Contribution (%), 2014
  • 8.3. Immuno Chemistry Market, United States, Revenue ($m), 2007-2014
  • 8.4. Immuno Chemistry Market, United States, Revenue ($m), 2014-2021
  • 8.5. Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 8.6. Immuno Chemistry Market, United States, Company Share by Revenue ($m), 2014

9. Infectious Diagnostics Market, United States

  • 9.1. Infectious Diagnostics Market, United States, Revenue Mix ($m), 2014
  • 9.2. Infectious Diagnostics Market, United States, Segment Contribution (%), 2014
  • 9.3. Infectious Diagnostics Market, United States, Revenue ($m), 2007-2014
  • 9.4. Infectious Diagnostics Market, United States, Revenue ($m), 2014-2021
  • 8.5. Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 8.6. Infectious Diagnostics Market, United States, Company Share by Revenue ($m), 2014

10. Microbiology Culture Market, United States

  • 10.1. Microbiology Culture Market, United States, Revenue Mix ($m), 2014
  • 10.2. Microbiology Culture Market, United States, Segment Contribution (%), 2014
  • 10.3. Microbiology Culture Market, United States, Revenue ($m), 2007-2014
  • 10.4. Microbiology Culture Market, United States, Revenue ($m), 2014-2021
  • 10.5. Microbiology Culture Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 10.6. Microbiology Culture Market, United States, Company Share by Revenue ($m), 2014

11. Overview of Key Companies in United States, In Vitro Diagnostics Market

  • 11.1. Siemens Healthcare
  • 11.2. F. Hoffmann-La Roche Ltd.
  • 11.3. Danaher Corporation
  • 11.4. Abbott Laboratories
  • 11.5. Becton, Dickinson and Company
  • 11.6. Hologic, Inc.
  • 11.7. bioMerieux S.A.
  • 11.8. Qiagen N.V.
  • 11.9. Bio-Rad Laboratories, Inc.
  • 11.10. Alere Inc.
  • 11.11. Thermo Fisher Scientific Inc.
  • 11.12. Immucor, Inc.
  • 11.13. Ortho-Clinical Diagnostics Inc.
  • 11.14. Sysmex Corporation
  • 11.15. Cepheid
  • 11.16. PerkinElmer, Inc.

12. In Vitro Diagnostics Market Pipeline Products

13. Financial Deals Landscape

  • 13.1. Acquisition
  • 13.2. Asset Transactions
  • 13.3. Debt Offerings
  • 13.4. Equity Offerings
  • 13.5. Merger
  • 13.6. Partnerships
  • 13.7. Private Equity
  • 13.8. Venture Financing

14. Appendix

  • 14.1. Research Methodology
  • 14.2. GlobalData Consulting
  • 14.3. Contact Us
  • 14.4. Disclaimer

List of Tables

  • Table 1: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, 2007-2021
  • Table 2: In Vitro Diagnostics Market, United States, Category Contribution by Revenue ($m), 2014
  • Table 3: In Vitro Diagnostics Market, United States, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Table 4: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 5: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 6: In Vitro Diagnostics Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 7: Clinical Chemistry Market, United States, Segment Contribution (%), 2014
  • Table 8: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 9: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 10: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 11: Urine Analysis Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 12: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 13: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 14: Urine Analysis Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 15: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 16: Clinical Chemistry Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 17: Clinical Chemistry Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 18: Genetic Testing Market, United States, Segment Contribution (%), 2014
  • Table 19: Genetic Testing Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 20: Genetic Testing Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 21: Genetic Testing Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 22: Genetic Testing Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 23: Haematology Market, United States, Segment Contribution (%), 2014
  • Table 24: Haematology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 25: Haematology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 26: Haematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 27: Haematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 28: Haematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 29: Haemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 30: Immunohaematology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 31: Haematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 32: Haematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 33: Haematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 34: Haemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 35: Immunohaematology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 36: Haematology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 37: Haematology Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 38: Histology And Cytology Market, United States, Segment Contribution (%), 2014
  • Table 39: Histology and Cytology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 40: Histology and Cytology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 41: Histology and Cytology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 42: Histology and Cytology Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 43: Immuno Chemistry Market, United States, Segment Contribution (%), 2014
  • Table 44: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 45: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 46: Anemia Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 47: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 48: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 49: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 50: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 51: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 52: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 53: Anemia Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 54: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 55: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 56: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 57: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 58: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 59: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 60: Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 61: Immuno Chemistry Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 62: Infectious Diagnostics Market, United States, Segment Contribution (%), 2014
  • Table 63: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 64: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 65: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 66: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 67: Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 68: Infectious Diagnostics Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 69: Microbiology Culture Market, United States, Segment Contribution (%), 2014
  • Table 70: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 71: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 72: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 73: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 74: Microbiology Culture Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 75: Microbiology Culture Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 76: In Vitro Diagnostics Market Pipeline Products
  • Table 77: OpGen Acquires AdvanDx
  • Table 78: Charles River Labs Acquires Celsis International for USD212 Million
  • Table 79: Alere Acquires US Diagnostics USD60 Million
  • Table 80: Integra LifeSciences Acquires TEI Medical and TEI Biosciences for USD312 Million
  • Table 81: Bio-Techne to Acquire Cliniqa
  • Table 82: Beijing Bohui Innovation Acquires Advion for USD28 Million
  • Table 83: Unchained Labs Acquires AVIA Biosystems
  • Table 84: Bioheart to Acquire Pavillion Scientific
  • Table 85: Opko Health to Acquire Bio-Reference Labs for USD1.47 Billion
  • Table 86: Eurofins Scientific to Acquire Diatherix Labs for USD50 Million
  • Table 87: Quest Diagnostics May Sell itself
  • Table 88: GeneNews and Cobalt Healthcare Acquire 33% Stake in Innovative Diagnostic Labs from Health Diagnostic Labs for USD4 Million
  • Table 89: Progen Pharma to Acquire TBG
  • Table 90: Progenity Acquires Carmenta Bioscience
  • Table 91: Illinois Health and Science Acquires IBA Molecular North America from IBA Molecular
  • Table 92: Roche Acquires CAPP Medical
  • Table 93: Rosetta Genomics Acquires PersonalizeDx from Prelude
  • Table 94: Global Enterprises to Acquire Majority Stake in Predictive Therapeutics
  • Table 95: Vivione Biosciences Announces the Expiration of Agreement to Acquire Trillium Diagnostics for USD15 Million
  • Table 96: Abcam Acquires Firefly BioWorks for USD28 Million in Tender Offer
  • Table 97: DNA Electronics Acquires NanoMR for up to USD24 Million
  • Table 98: Amarantus BioScience Acquires DioGenix
  • Table 99: Adaptive Biotech Acquires Sequenta
  • Table 100: Aegis Sciences Corporation Acquires Diagnovus
  • Table 101: Roche Acquires Bina Technologies
  • Table 102: Eurofins Scientific Acquires Boston Heart Diagnostics
  • Table 103: LabCorp Acquires Bode Technology from SolutionPoint
  • Table 104: Roche Acquires Ariosa Diagnostics
  • Table 105: Noble Life Sciences Acquires Spring Valley Labs
  • Table 106: IBM Watson Invests in Pathway Genomics
  • Table 107: LabCorp Acquires Covance for USD6.1 Billion
  • Table 108: PDI Acquires RedPath Integrated Pathology for USD23 Million
  • Table 109: Optum to Acquire Alere for USD600 Million
  • Table 110: Sigma-Aldrich Acquires Cell Marque
  • Table 111: Immucor Acquires Sentilus
  • Table 112: Neogen Acquires BioLumix
  • Table 113: LabCorp Acquires LipoScience for USD85.3 Million
  • Table 114: Merck to Acquire Sigma-Aldrich for USD17 Billion
  • Table 115: Ron Zwanziger Plans to Acquire Alere for USD3.82 Billion
  • Table 116: Veracyte Acquires Allegro Diagnostics for USD21 Million
  • Table 117: Nanosphere Plans to Sell Itself
  • Table 118: American Liberty Petroleum Acquires Avant Diagnostics
  • Table 119: Orgentec Diagnostika to Acquire Corgenix Medical for USD16 Million
  • Table 120: Roper Industries Acquires Innovative Product Achievements
  • Table 121: WholeHealth Products Acquires Rapid Results, Medical Diagnostic Distribution Company
  • Table 122: Valeant Pharma to Acquire Rights to IBSchek in US and Canada form Commonwealth Labs
  • Table 123: Xagenic Acquires Rights to Detection Technology from University of Toronto

List of Figures

  • Figure 1: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, 2007-2021
  • Figure 2: In Vitro Diagnostics Market, United States, Revenue Mix ($m), 2014
  • Figure 3: In Vitro Diagnostics Market, United States, Category Contribution (%), 2014
  • Figure 4: In Vitro Diagnostics Market, United States, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Figure 5: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 6: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 7: In Vitro Diagnostics Market, United States, Company Share (%) 2014
  • Figure 8: Clinical Chemistry Market, United States, Revenue Mix ($m), 2014
  • Figure 9: Clinical Chemistry Market, United States, Segment Contribution (%), 2014
  • Figure 10: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 11: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 12: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 13: Urine Analysis Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 14: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 15: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 16: Urine Analysis Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 17: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 18: Clinical Chemistry Market, United States, Company Share (%) 2014
  • Figure 19: Genetic Testing Market, United States, Revenue Mix ($m), 2014
  • Figure 20: Genetic Testing Market, United States, Segment Contribution (%), 2014
  • Figure 21: Genetic Testing Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 22: Genetic Testing Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 23: Genetic Testing Market, United States, Company Share (%) 2014
  • Figure 24: Haematology Market, United States, Revenue Mix ($m), 2014
  • Figure 25: Haematology Market, United States, Segment Contribution (%), 2014
  • Figure 26: Haematology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 27: Haematology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 28: Haematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 29: Haematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 30: Haematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 31: Haemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 32: Immunohaematology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 33: Haematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 34: Haematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 35: Haematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 36: Haemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 37: Immunohaematology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 38: Haematology Market, United States, Company Share (%) 2014
  • Figure 39: Histology And Cytology Market, United States, Revenue Mix ($m), 2014
  • Figure 40: Histology And Cytology Market, United States, Segment Contribution (%), 2014
  • Figure 41: Histology and Cytology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 42: Histology and Cytology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 43: Histology and Cytology Market, United States, Company Share (%) 2014
  • Figure 44: Immuno Chemistry Market, United States, Revenue Mix ($m), 2014
  • Figure 45: Immuno Chemistry Market, United States, Segment Contribution (%), 2014
  • Figure 46: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 47: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 48: Anemia Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 49: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 50: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 51: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 52: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 53: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 54: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 55: Anemia Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 56: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 57: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 58: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 59: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 60: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 61: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 62: Immuno Chemistry Market, United States, Company Share (%) 2014
  • Figure 63: Infectious Diagnostics Market, United States, Revenue Mix ($m), 2014
  • Figure 64: Infectious Diagnostics Market, United States, Segment Contribution (%), 2014
  • Figure 65: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 66: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 67: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 68: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 69: Infectious Diagnostics Market, United States, Company Share (%) 2014
  • Figure 70: Microbiology Culture Market, United States, Revenue Mix ($m), 2014
  • Figure 71: Microbiology Culture Market, United States, Segment Contribution (%), 2014
  • Figure 72: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 73: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 74: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 75: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 76: Microbiology Culture Market, United States, Company Share (%) 2014
Back to Top